RCI(RCI)
RCI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $23.15B | $23.42B | $23.74B |
| Low | $22.98B | $23.32B | $23.56B |
| High | $23.51B | $23.64B | $24.10B |
| EBITDA Avg | $9.48B | $9.50B | $9.70B |
| Low | $9.40B | $9.22B | $9.67B |
| High | $9.58B | $9.86B | $9.75B |
| EBIT Avg | $4.67B | $4.73B | $4.95B |
| Low | $4.58B | $4.44B | $4.92B |
| High | $4.77B | $5.09B | $5.00B |
| Net Income Avg | $1.85B | $1.90B | $2.06B |
| Low | $1.79B | $1.68B | $2.04B |
| High | $1.93B | $2.17B | $2.10B |
| EPS Avg | $3.43 | $3.51 | $3.81 |
| Low | $3.31 | $3.12 | $3.78 |
| High | $3.56 | $4.01 | $3.89 |
| Analysts (Rev / EPS) | 10 / 12 | 10 / 12 | 4 / 6 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $5.52B | $6.26B | $5.71B | $5.86B | $5.82B | $5.86B |
| Low | $5.47B | $6.24B | $5.66B | $5.81B | $5.77B | $5.81B |
| High | $5.54B | $6.31B | $5.76B | $5.91B | $5.87B | $5.91B |
| EBITDA Avg | $2.39B | $2.45B | $2.26B | $2.32B | $2.40B | $2.49B |
| Low | $2.28B | $2.39B | $2.25B | $2.31B | $2.39B | $2.48B |
| High | $2.59B | $2.54B | $2.27B | $2.32B | $2.41B | $2.50B |
| EBIT Avg | $1.17B | $1.23B | $1.04B | $1.11B | $1.19B | $1.28B |
| Low | $1.05B | $1.17B | $1.04B | $1.10B | $1.18B | $1.27B |
| High | $1.37B | $1.32B | $1.05B | $1.11B | $1.20B | $1.29B |
| Net Income Avg | $485M | $530M | $393M | $439M | $503M | $573M |
| Low | $402M | $490M | $388M | $434M | $497M | $566M |
| High | $636M | $599M | $397M | $444M | $508M | $579M |
| EPS Avg | $0.90 | $0.98 | $0.73 | $0.81 | $0.93 | $1.06 |
| Low | $0.74 | $0.91 | $0.72 | $0.80 | $0.92 | $1.05 |
| High | $1.18 | $1.11 | $0.74 | $0.82 | $0.94 | $1.07 |
| Analysts (Rev / EPS) | 5 / 9 | 4 / 8 | 2 / 3 | 2 / 4 | 2 / 3 | 2 / 4 |